318 related articles for article (PubMed ID: 34048655)
21. Allosteric Modulation of Adenosine A
Korkutata M; Agrawal L; Lazarus M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216213
[TBL] [Abstract][Full Text] [Related]
22. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
Pandey P; Roy KK; Doerksen RJ
J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
[TBL] [Abstract][Full Text] [Related]
23. Recent Advances in the In-silico Structure-based and Ligand-based Approaches for the Design and Discovery of Agonists and Antagonists of A2A Adenosine Receptor.
Agrawal N; Chandrasekaran B; Al-Aboudi A
Curr Pharm Des; 2019; 25(7):774-782. PubMed ID: 30848185
[TBL] [Abstract][Full Text] [Related]
24. In search of novel ligands using a structure-based approach: a case study on the adenosine A
Lenselink EB; Beuming T; van Veen C; Massink A; Sherman W; van Vlijmen HW; IJzerman AP
J Comput Aided Mol Des; 2016 Oct; 30(10):863-874. PubMed ID: 27629350
[TBL] [Abstract][Full Text] [Related]
25. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
Sabbadin D; Ciancetta A; Moro S
J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
[TBL] [Abstract][Full Text] [Related]
26. Dynamic Role of the G Protein in Stabilizing the Active State of the Adenosine A
Lee S; Nivedha AK; Tate CG; Vaidehi N
Structure; 2019 Apr; 27(4):703-712.e3. PubMed ID: 30713025
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of the adenosine A
Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
[TBL] [Abstract][Full Text] [Related]
28. Activation of adenosine A
Mizumura T; Kondo K; Kurita M; Kofuku Y; Natsume M; Imai S; Shiraishi Y; Ueda T; Shimada I
Sci Adv; 2020 Mar; 6(12):eaay8544. PubMed ID: 32206717
[TBL] [Abstract][Full Text] [Related]
29. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
[TBL] [Abstract][Full Text] [Related]
30. Role of Extracellular Loops and Membrane Lipids for Ligand Recognition in the Neuronal Adenosine Receptor Type 2A: An Enhanced Sampling Simulation Study.
Cao R; Giorgetti A; Bauer A; Neumaier B; Rossetti G; Carloni P
Molecules; 2018 Oct; 23(10):. PubMed ID: 30322034
[TBL] [Abstract][Full Text] [Related]
31. The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs.
Fan F; Toledo Warshaviak D; Hamadeh HK; Dunn RT
PLoS One; 2019; 14(1):e0204378. PubMed ID: 30605479
[TBL] [Abstract][Full Text] [Related]
32. Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives.
Al-Attraqchi OHA; Attimarad M; Venugopala KN; Nair A; Al-Attraqchi NHA
Curr Pharm Des; 2019; 25(25):2716-2740. PubMed ID: 31333093
[TBL] [Abstract][Full Text] [Related]
33. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
[TBL] [Abstract][Full Text] [Related]
34. Ultraslow Water-Mediated Transmembrane Interactions Regulate the Activation of A2A Adenosine Receptor.
Lee Y; Kim S; Choi S; Hyeon C
Biophys J; 2016 Sep; 111(6):1180-1191. PubMed ID: 27653477
[TBL] [Abstract][Full Text] [Related]
35. Activation of the A2A adenosine G-protein-coupled receptor by conformational selection.
Ye L; Van Eps N; Zimmer M; Ernst OP; Prosser RS
Nature; 2016 May; 533(7602):265-8. PubMed ID: 27144352
[TBL] [Abstract][Full Text] [Related]
36. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
Bartuzi D; Kaczor AA; Matosiuk D
Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
[TBL] [Abstract][Full Text] [Related]
37. Antagonist binding and induced conformational dynamics of GPCR A2A adenosine receptor.
Pang X; Yang M; Han K
Proteins; 2013 Aug; 81(8):1399-410. PubMed ID: 23508898
[TBL] [Abstract][Full Text] [Related]
38. High ligand efficiency quinazoline compounds as novel A
Bolteau R; Duroux R; Laversin A; Vreulz B; Shiriaeva A; Stauch B; Han GW; Cherezov V; Renault N; Barczyk A; Ravez S; Coevoet M; Melnyk P; Liberelle M; Yous S
Eur J Med Chem; 2022 Nov; 241():114620. PubMed ID: 35933788
[TBL] [Abstract][Full Text] [Related]
39. Structural basis for allosteric regulation of GPCRs by sodium ions.
Liu W; Chun E; Thompson AA; Chubukov P; Xu F; Katritch V; Han GW; Roth CB; Heitman LH; IJzerman AP; Cherezov V; Stevens RC
Science; 2012 Jul; 337(6091):232-6. PubMed ID: 22798613
[TBL] [Abstract][Full Text] [Related]
40. Binding mode similarity measures for ranking of docking poses: a case study on the adenosine A2A receptor.
Anighoro A; Bajorath J
J Comput Aided Mol Des; 2016 Jun; 30(6):447-56. PubMed ID: 27334985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
